GENE ONLINE|News &
Opinion
Blog

2025-06-20| US BIO 2025

“The Tide of Capital Ebbs and Flows with Technology”: BIO 2025 Investor Perspectives on AI and Digital Health

by Oscar Wu
Share To
In the first half of 2025, two prominent Boston-based healthcare investment firms—Flare Capital Partners and Valspring Capital—offered rare insights at the BIO International Convention on how the venture capital landscape is evolving in artificial intelligence (AI) and digital health. As Flare Capital’s partner and physician-investor Dr. Dan Gebremedhin outlined, AI has entered what he describes … “The Tide of Capital Ebbs and Flows with Technology”: BIO 2025 Investor Perspectives on AI and Digital Health Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.

GO Prime with only $1.49 now

LATEST
Phosphorylation and Ubiquitination Mechanisms Linked to Rosacea Pathogenesis
2026-10-10
Malin and Goetz Updates SPF 30 Mineral Sunscreen Documentation on DailyMed
2026-10-09
Henry Schein Updates Vitamin A & D Ointment Product Documentation on DailyMed
2026-10-09
Mary Kay Updates Clear Proof Acne Treatment Gel Labeling in DailyMed Database
2026-10-09
Dechra Veterinary Products Updates Muricin Ointment Documentation on DailyMed
2026-10-09
Cardinal Health Updates LEADER Daily Moisturizer Product Documentation on DailyMed
2026-10-09
S.S.S. Company Updates Curasore Pramoxine Hydrochloride Product Information on DailyMed
2026-10-09
EVENT
Scroll to Top